Literature DB >> 31106352

Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Joseph Meletiadis1,2, Maria Siopi1, Lamprini Kanioura2, Karin Meinike Jørgensen3, David S Perlin4, Johan W Mouton2, Maiken Cavling Arendrup3,5,6.   

Abstract

BACKGROUND: Reference antifungal susceptibility testing of echinocandins against Aspergillus spp. relies on the determination of the minimal effective concentration, which is difficult to perform, time-consuming and subjective. We developed and evaluated in a multicentre study an agar-based screening method for echinocandin susceptibility testing of Aspergillus spp.
METHODS: Forty WT isolates [10 Aspergillus fumigatus species complex (SC), 10 Aspergillus flavus SC, 10 Aspergillus terreus SC and 10 Aspergillus niger SC] and 4 non-WT A. fumigatus isolates with or without known fks alterations were used. The optimal test conditions and stability over time were evaluated in preliminary studies monitoring colony growth. Twenty-microlitre aliquots of 1-2 McFarland inocula in 0.1% Tween 20 aqueous solution were added to each well and plates were incubated for 24/48 h at 35 ± 2°C. Subsequently, all isolates were tested blindly at three centres using four-well screening plates, containing anidulafungin, caspofungin, micafungin or no antifungal in each of the four wells, respectively.
RESULTS: WT isolates produced fluffy colonies on drug-free agar wells only. The non-WT isolates produced fluffy colonies on echinocandin-containing and control agar wells. Using the echinocandin concentrations of 0.25 mg/L anidulafungin, 1 mg/L caspofungin and 0.125 mg/L micafungin, and the compact (non-fluffy) versus fluffy colony morphology endpoint, all centres successfully discriminated non-WT and WT strains even after 24 h. Among the three echinocandins, anidulafungin produced the clearest endpoints.
CONCLUSIONS: The four-well plate agar method is suitable for echinocandin susceptibility screening of Aspergillus spp. and can be used to detect echinocandin non-WT isolates.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31106352      PMCID: PMC6640300          DOI: 10.1093/jac/dkz154

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  34 in total

Review 1.  Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.

Authors:  R E Gardiner; P Souteropoulos; S Park; D S Perlin
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

2.  Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.

Authors:  A Espinel-Ingroff; B Arthington-Skaggs; N Iqbal; D Ellis; M A Pfaller; S Messer; M Rinaldi; A Fothergill; D L Gibbs; A Wang
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

3.  A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.

Authors:  Eleusa Maria F Rocha; Guillermo Garcia-Effron; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

4.  Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.

Authors:  S P Hawser; C Jessup; J Vitullo; M A Ghannoum
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Bianca A Bouman; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

6.  Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp.

Authors:  Sevtap Arikan; Pinar Yurdakul; Gulsen Hascelik
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).

Authors:  Ana Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.

Authors:  D T A Te Dorsthorst; R B M Groot Zwaaftink; A J M M Rijs; J Meletiadis; P E Verweij
Journal:  Med Mycol       Date:  2007-06       Impact factor: 4.076

9.  Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.

Authors:  S Arunmozhi Balajee; Mark D Lindsley; Naureen Iqbal; James Ito; Peter G Pappas; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.

Authors:  S Eschertzhuber; C Velik-Salchner; C Hoermann; D Hoefer; C Lass-Florl
Journal:  Transpl Infect Dis       Date:  2007-07-01       Impact factor: 2.228

View more
  5 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 2.  Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

Authors:  Amir Arastehfar; Toni Gabaldón; Rocio Garcia-Rubio; Jeffrey D Jenks; Martin Hoenigl; Helmut J F Salzer; Macit Ilkit; Cornelia Lass-Flörl; David S Perlin
Journal:  Antibiotics (Basel)       Date:  2020-12-08

3.  Echinocandins and Their Activity against Aspergillus terreus Species Complex: a Novel Agar Screening Method.

Authors:  Nina Lackner; Roya Vahedi-Shahandashti; Sonja Jähnig; Lea Schönherr; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2021-12-13       Impact factor: 5.938

Review 4.  Echinocandins - structure, mechanism of action and use in antifungal therapy.

Authors:  Mateusz Szymański; Sandra Chmielewska; Urszula Czyżewska; Marta Malinowska; Adam Tylicki
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

5.  Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip.

Authors:  Giuliana Lo Cascio; Alda Bazaj; Laura Trovato; Silvana Sanna; Stefano Andreoni; Elisabetta Blasi; Marco Conte; Paolo Fazii; Ester Oliva; Valentina Lepera; Gianluigi Lombardi; Claudio Farina
Journal:  Infect Drug Resist       Date:  2022-10-04       Impact factor: 4.177

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.